Expanded ATXN10 Alleles in Neurodegenerative Disorders: A Case Series and Review of the Literature
- Mario Cornejo-Olivas(corresponding author),
- Angelica Raney,
- ,
- Kamilla Sedov,
- ,
- Harmony M. Sosa
- ,
- ,
- docencia y atención especializada en epilepsia,
- Division of Immunology and Rheumatology Stanford School of Medicine,
- Department of Pathology,
- Universidad Científica del Sur
Open access
Publication Information
Output type
Original language
EnglishJournal (Volume, Issue Number)
Movement Disorders Clinical PracticePublication milestones
- Accepted/In press - 2026
Publication status
Publication IDs
- Scopus: 105046866990
Abstract
Background: Spinocerebellar ataxia type 10 (SCA10 or ATX-ATXN10) is typically attributed to large intronic ATTCT repeat expansions in ATXN10, yet interpretation is complicated by repeat interruptions, reduced penetrance, and assay limitations. Cases: We describe three patients referred for SCA10 evaluation in whom ATXN10 repeat-primed PCR (RP-PCR) reported “>32 repeats, probable pathogenic.” Targeted long-read sequencing (LRS) identified two individuals with intermediate, mixed repeat tracts (~100–150 repeats) and one individual with a very large, highly pure ATTCT expansion (~1127 repeats). Each phenotype was explained by an alternative disorder: spastic ataxia syndrome caused by biallelic pathogenic FA2H variants (HSP/ATX-FA2H), full-penetrance ATXN3 CAG expansion consistent with SCA3/ATX-ATXN3, and clinically established MSA-C. Literature Review: We identified three studies reporting four ATX-ATXN10 cases coexisting with Huntington's disease (one case) and SCA2/ATX-ATXN2 (three cases). Conclusion: Our three cases suggest that intermediate ATXN10 alleles in the 100–150 range may not be pathogenic and large ATXN10 expansions remain probably pathogenic in most patients with a compatible autosomal-dominant ataxia phenotype. Comprehensive genetic testing beyond RP-PCR is necessary for accurate diagnosis.
